Dr. Vinita E. Verghese, MD

Dr. Verghese practices at Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center.

Dr. Verghese's NPI, 1952305880, was assigned on June 9, 2005. Dr. Verghese graduated from MCP-Hahnemann College of Medicine in 1984. Dr. Verghese holds California license G75423.

Dr. Verghese's primary practice is Eisenhower Health, at 39-000 Bob Hope Drive, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 340-3911. Dr. Verghese also practices at Eisenhower Medical Center, 39000 Bob Hope Dr, Rancho Mirage, CA 92270.

Dr. Verghese's primary practice is Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center. Dr. Verghese is also affiliated with Desert Regional Medical Center. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Verghese to 3 more home health agencies, 1 breast imaging center, 1 clinical lab, 1 dialysis center and 1 skilled nursing facility, each named with a free account. Dr. Verghese's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Verghese practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Verghese's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Verghese is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Verghese's licenses on file in 3 states: California, Michigan and Pennsylvania.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, alzheimer's disease, ankle or foot injury, anxiety, aortic atherosclerois and arthritis among the conditions Dr. Verghese treats.

CMS data shows 1,104 Medicare services from Dr. Verghese across 14 procedure codes in 2024, for 317 Medicare patients. Medicare paid $67,778 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 317 Medicare patients who saw Dr. Verghese in 2024. The largest group is 75 to 84, with 141 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Verghese's median patient age at 79, with 66% women.

In 2024, Dr. Verghese wrote 4,854 Medicare Part D claims for 316 patients. 83% of them were for generic drugs. CMS names the drug for 4,029 of them, across 116 drugs with 11 or more claims each, at $621,784 in total drug cost. In 2023, CMS named 3,777 claims across 111 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Verghese for performance year 2024, reported as part of a group. Dr. Verghese accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Verghese as offering telehealth.

CMS Open Payments shows 5 general payments to Dr. Verghese from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $119.

Dr. Verghese graduated from MCP-Hahnemann College of Medicine in 1984.

Dr. Verghese is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.